Pentoxifylline and cardiorenal outcomes in advanced CKD with untreated dyslipidemia: a longitudinal cohort study
Ren Fail. 2026 Dec;48(1):2694246. doi: 10.1080/0886022X.2026.2694246. Epub 2026 Jul 2.ABSTRACTBACKGROUND: Patients with advanced chronic kidney disease (CKD) and dyslipidemia are at high risk of kidney failure and cardiovascular events, yet many do not receive lipid-lowering therapy. Pentoxifylline

